CYCLOPHOSPHAMIDE

Generic: CYCLOPHOSPHAMIDE

Nexus PharmaceuticalsManufacturer
INTRAVENOUSRoute
CYCLOPHOSPHAMIDEActive Substance
2024-10-29Original Approval

CYCLOPHOSPHAMIDE is FDA application ANDA216783, sponsored by NEXUS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.

Recalls

Top Reported Reactions

1
OFF LABEL USE
16,826 reports
2
FEBRILE NEUTROPENIA
14,787 reports
3
DRUG INEFFECTIVE
10,788 reports
4
NEUTROPENIA
10,780 reports
5
PYREXIA
9,368 reports
6
DISEASE PROGRESSION
8,229 reports
7
PNEUMONIA
6,779 reports
8
THROMBOCYTOPENIA
6,679 reports
9
PRODUCT USE IN UNAPPROVED INDICATION
6,563 reports
10
NAUSEA
6,354 reports